M&A Deal Summary

Haemonetics Acquires OpSens

On October 10, 2023, Haemonetics acquired medical products company OpSens for 253M USD

Acquisition Highlights
  • This is Haemonetics’ 8th transaction in the Medical Products sector.
  • This is Haemonetics’ 3rd largest (disclosed) transaction.
  • This is Haemonetics’ 2nd transaction in Canada.
  • This is Haemonetics’ 1st transaction in Quebec.

M&A Deal Summary
Date 2023-10-10
Target OpSens
Sector Medical Products
Buyer(s) Haemonetics
Deal Type Add-on Acquisition
Deal Value 253M USD
Advisor(s) Piper Sandler & Co. (Financial)
Norton Rose Fulbright (Legal)

Target

OpSens

Quebec City, Quebec, Canada
OpSens is a medical device cardiology-focused company delivering innovative solutions based on its proprietary optical technology. The company offers commercially and clinically validated optical technology for use primarily in interventional cardiology. Its core products include the SavvyWir, a sensor-guided 3-in-1 guidewire for TAVR procedures, that acts as a pacing and pressure monitoring wire advancing the workflow of the procedure and enabling potentially shorter hospital stays for patients, and the OptoWire, a pressure guidewire that aims to improve clinical outcomes by accurately and consistently measuring Fractional Flow Reserve (FFR) and diastolic pressure ratio (dPR) to aid clinicians in the diagnosis and treatment of patients with coronary artery disease. OpSens is based in Quebec City.

Search 201,292 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Buyer(S) 1

Buyer

Haemonetics

Boston, Massachusetts, United States
Category Company
Founded 1971
Sector Medical Products
Employees2,708
Revenue 1.3B USD (2024)
DESCRIPTION

Haemonetics is a healthcare company dedicated to providing innovative blood management solutions for customers. The company devices and consumables, information technology platforms, and consulting services deliver a suite of business solutions to help customers improve clinical outcomes and reduce the cost of healthcare for blood collectors, hospitals, and patients worldwide. Haemonetics was founded in 1971 and is based in Boston, Massachusetts.

DEAL STATS #
Overall 14 of 15
Sector (Medical Products) 8 of 8
Type (Add-on Acquisition) 13 of 14
State (Quebec) 1 of 1
Country (Canada) 2 of 2
Year (2023) 1 of 1
Size (of disclosed) 3 of 10
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2021-01-20 Cardiva Medical

Sunnyvale, California, United States

Cardiva Medical, Inc. is a provider of offers Cardiva Catalyst II that supports the body's natural healing process by enhancing the vessel's inherent natural elastic recoil. Cardiva Medical is based in Sunnyvale, California.

Buy $475M
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2024-03-05 Attune Medical

Chicago, Illinois, United States

Attune Medical is a manufacturer of the ensoETM proactive esophageal cooling device, the only FDA-cleared temperature regulation device indicated for esophageal protection during radiofrequency (RF) cardiac ablation procedures. Attune Medical is based in Chicago, Illinois.

Buy -
Mergr

Product

Company

Legal